ChemSpider 2D Image | Darifenacin Hydrobromide | C28H31BrN2O2

Darifenacin Hydrobromide

  • Molecular FormulaC28H31BrN2O2
  • Average mass507.462 Da
  • Monoisotopic mass506.156891 Da
  • ChemSpider ID392053
  • defined stereocentres - 1 of 1 defined stereocentres


More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

Darifenacin Hydrobromide [JAN] [USAN]
(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide hydrobromide
133099-07-7 [RN]
2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide hydrobromide
2-{(3S)-1-[2-(2,3-dihydro-1-benzofur-5-yl)éthyl]pyrrolidin-3-yl}-2,2-diphénylacétamide bromhydrate
2-{(3S)-1-[2-(2,3-Dihydro-1-benzofur-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamidhydrobromid
2-{(3S)-1-[2-(2,3-Dihydro-1-benzofur-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamidhydrobromid(1:1)
2-{(3S)-1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide (1:1) [ACD/IUPAC Name]
2-{(3S)-1-[2-(2,3-Dihydro-1-benzofuran-5-yl)éthyl]-3-pyrrolidinyl}-2,2-diphénylacétamide, bromhydrate (1:1) [French] [ACD/IUPAC Name]
2-{(3S)-1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamidhydrobromid (1:1) [German] [ACD/IUPAC Name]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

UK-88525-04 (hydrobromide) [DBID]
10225902 [DBID]
D01699 [DBID]
UK-88525 [DBID]
UK-88525-04 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Chemical Class:

      The hydrobromide salt of darifenacin. A selective antagonist for the M<smallsub>3</smallsub> muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions, it is u sed in the management of urinary incontinence. ChEBI CHEBI:31455
      The hydrobromide salt of darifenacin. A selective antagonist for the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions, it is u; sed in the manageme nt of urinary incontinence. ChEBI https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:31455
      The hydrobromide salt of darifenacin. A selective antagonist for the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions, it is used in the management of urinary incontinence. ChEBI CHEBI:31455
    • Bio Activity:

      Darifenacin HBr(UK88525) is a selective M3 muscarinic receptor antagonist with pKi of 8.9. MedChem Express
      Darifenacin HBr(UK88525) is a selective M3 muscarinic receptor antagonist with pKi of 8.9.; IC50 value: 8.9 (pKi) [1]; Target: M3 receptor; in vitro: Darifenacin exerts non-parallel rightward displacement of the agonist curve and also significant depression of the maximum response (+)-cis-Dioxolane produced concentration-dependent contraction of the isolated bladder of rat [1]. MedChem Express HY-A0012
      GPCR/G protein MedChem Express HY-A0012
      GPCR/G protein; Neuronal Signaling; MedChem Express HY-A0012
      mAChR MedChem Express HY-A0012

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site






Advertisement